10/22/2026
VA faces challenges in psychedelic treatment rollout
Federal officials discuss the complexities of psychedelic access for veterans.
Topic archive
7 stories
10/22/2026
Federal officials discuss the complexities of psychedelic access for veterans.
9/16/2026
Phase 3 trial shows potential benefits for treatment-resistant depression.
9/15/2026
Exploring the promise and risks of psychedelic treatments in mental health.
9/15/2026
Trump's mention of psychedelic therapies sparks renewed interest in their potential applications.
8/19/2026
Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.
7/24/2026
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
7/15/2026
Federal support for ibogaine and other psychedelics aims to aid veterans with PTSD.